Crispr Therapeutics AG (CRSP) Receives a Buy from SVB Securities

In a report released on November 11, Mani Foroohar from SVB Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP - Research Report)....

Related Keywords

Switzerland ,Matthew Porteus ,Mani Foroohar ,Daniel Anderson ,Securitiess Silvan Tuerkcan ,Rodger Novak ,Emmanuelle Charpentier ,Shaun Patrick Foy ,Alnylam Pharma ,Rocket Pharmaceuticals ,Barclays ,Crispr Therapeutics ,Silvan Tuerkcan ,Chad Cowan ,Craig Mellow ,